Humana Inc. (NYSE:HUM) has received a consensus recommendation of “Buy” from the eighteen brokerages that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $486.92.
HUM has been the subject of several analyst reports. Seaport Global Securities initiated coverage on Humana in a report on Friday, July 9th. They set a “neutral” rating and a $455.65 target price for the company. Cowen started coverage on Humana in a report on Thursday, September 9th. They set an “outperform” rating and a $479.00 target price for the company. Barclays started coverage on Humana in a research report on Thursday, September 9th. They set an “overweight” rating and a $500.00 price target on the stock. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $490.00 price target on the stock in a research report on Friday, July 16th. Finally, Seaport Res Ptn reissued a “neutral” rating on shares of Humana in a research report on Friday, July 9th.
In other Humana news, Director David A. Jr/Ky Jones sold 4,800 shares of the company’s stock in a transaction dated Thursday, September 16th. The stock was sold at an average price of $401.00, for a total value of $1,924,800.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.40% of the company’s stock.
Shares of NYSE HUM traded up $13.15 during mid-day trading on Monday, hitting $433.84. 20,053 shares of the company traded hands, compared to its average volume of 896,439. Humana has a 1 year low of $370.22 and a 1 year high of $475.44. The stock has a market capitalization of $55.75 billion, a price-to-earnings ratio of 22.83, a PEG ratio of 1.42 and a beta of 0.89. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.41. The business has a 50 day moving average of $406.80 and a two-hundred day moving average of $428.72.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 28th. The insurance provider reported $6.89 EPS for the quarter, beating the consensus estimate of $6.86 by $0.03. Humana had a return on equity of 13.62% and a net margin of 3.09%. The business had revenue of $20.65 billion during the quarter, compared to the consensus estimate of $20.51 billion. As a group, research analysts anticipate that Humana will post 21.49 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 29th. Shareholders of record on Thursday, September 30th will be given a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 0.65%. The ex-dividend date is Wednesday, September 29th. Humana’s payout ratio is currently 14.93%.
Humana Company Profile
Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts.
Recommended Story: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.